Table 1.
Core (both criteria required) |
1. Slowly progressive or stepwise progressive, focal, asymmetric limb weakness; that is, motor involvement in the motor nerve distribution of at least two nerves for more than 1 month. If symptoms and signs are present only in the distribution of one nerve, only a possible diagnosis can be made. |
2. No objective sensory abnormalities except for minor vibration sense abnormalities in the lower limbs. |
Supportive |
3. Predominant upper limb involvement. |
4. Decreased or absent tendon reflexes in the affected limb. |
5. Absence of cranial nerve involvement. |
6. Cramps and fasciculations in the affected limb. |
7. Response in terms of disability or muscle strength to immunomodulatory therapy. |
Exclusion criteria |
8. Upper motor neuron signs. |
9. Marked bulbar involvement. |
10. Sensory impairment more marked than minor vibration loss in the lower limbs. |
11. Diffuse symmetric weakness during the initial weeks. |
Note: Copyright © 2010 Peripheral Nerve Society. Reproduced with permission from John Wiley & Sons, Inc. Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision. J Peripher Nerv Syst. 2010;15(4):295–301.
Abbreviation: MMN, multifocal motor neuropathy.